D Pittet, B Thievent, RP Wenzel, N Li, R Auckenthaler and PM Suter
Department of Internal Medicine, University Hospital of Geneva, Switzerland.

The prognosis in patients with sepsis depends on severity of acute illness, underlying chronic diseases, and complications associated with infection. Adjusting for these factors is essential for evaluation of new therapies. The purpose of the present study was to determine variables readily identifiable at the bedside that predict mortality in intensive care unit (ICU) patients with sepsis and positive blood cultures. For a 5-yr period, all patients of a surgical ICU presenting with positive blood cultures and sepsis were systematically analyzed for clinical variables and organ dysfunctions at the day of onset of sepsis and bacteremia and during the subsequent clinical course. The prognostic value of these variables was determined using logistic regression procedures. Of the 5,457 admissions to the ICU, 176 patients developed sepsis with positive blood cultures (3.2 per 100 admissions). The fatality rate was 35% at 28 days after the onset of sepsis; in- hospital mortality was 43%. Independent predictors of mortality at onset of sepsis were previous antibiotic therapy (odds ratio [OR], 2.40; 95% confidence interval [CI95], 1.59 to 3.62; p = 0.034), hypothermia (OR, 1.43; CI95, 1.04 to 2.44; p = 0.030), requirement for mechanical ventilation (OR, 2.97; CI95, 1.96 to 4.51; p = 0.009), and onset-of-sepsis APACHE II score (OR, 1.21; CI95, 1.13 to 1.29; p < 0.001). Vital organ dysfunctions developing after the onset of sepsis influenced outcome markedly. The best two independent prognostic factors were the APACHE II score at the onset of sepsis (OR, 1.13 per unit; CI95, 1.08 to 1.17; p = 0.0016) and the number of organ dysfunctions developing thereafter (OR, 2.39; CI95, 2.02 to 2.82; p < 0.001). In ICU patients with sepsis and positive blood cultures, outcome can be predicted by the severity of illness at onset of sepsis and the number of vital organ dysfunctions developing subsequently. These variables are easily assessed at the bedside and should be included in the evaluation of new therapeutic strategies.

This article has been cited by other articles:

				S. N. Linch, A. M. Kelly, E. T. Danielson, R. Pero, J. J. Lee, and J. A. Gold Mouse Eosinophils Possess Potent Antibacterial Properties In Vivo Infect. Immun., November 1, 2009; 77(11): 4976 - 4982. [Abstract] [Full Text] [PDF]

				A. Ashare, A. B. Nymon, K. C. Doerschug, J. M. Morrison, M. M. Monick, and G. W. Hunninghake Insulin-like Growth Factor-1 Improves Survival in Sepsis via Enhanced Hepatic Bacterial Clearance Am. J. Respir. Crit. Care Med., July 15, 2008; 178(2): 149 - 157. [Abstract] [Full Text] [PDF]

				V. D. Rosenthal, D. G. Maki, R. Salomao, C. A. Moreno, Y. Mehta, F. Higuera, L. E. Cuellar, O. A. Arikan, R. Abouqal, H. Leblebicioglu, et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med, October 17, 2006; 145(8): 582 - 591. [Abstract] [Full Text] [PDF]

				A. Ashare, M. M. Monick, L. S. Powers, T. Yarovinsky, and G. W. Hunninghake Severe Bacteremia Results in a Loss of Hepatic Bacterial Clearance Am. J. Respir. Crit. Care Med., March 15, 2006; 173(6): 644 - 652. [Abstract] [Full Text] [PDF]

				C. Alberti, C. Brun-Buisson, S. Chevret, M. Antonelli, S. V. Goodman, C. Martin, R. Moreno, A. R. Ochagavia, M. Palazzo, K. Werdan, et al. Systemic Inflammatory Response and Progression to Severe Sepsis in Critically Ill Infected Patients Am. J. Respir. Crit. Care Med., March 1, 2005; 171(5): 461 - 468. [Abstract] [Full Text] [PDF]

				C.-I. Kang, S.-H. Kim, W. B. Park, K.-D. Lee, H.-B. Kim, E.-C. Kim, M.-d. Oh, and K.-W. Choe Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli: Risk Factors for Mortality and Impact of Inappropriate Initial Antimicrobial Therapy on Outcome Antimicrob. Agents Chemother., February 1, 2005; 49(2): 760 - 766. [Abstract] [Full Text] [PDF]

				A. Corona, A. P. R. Wilson, M. Grassi, and M. Singer Prospective audit of bacteraemia management in a university hospital ICU using a general strategy of short-course monotherapy J. Antimicrob. Chemother., October 1, 2004; 54(4): 809 - 817. [Abstract] [Full Text] [PDF]

				J. A. Cepeda, T. Whitehouse, B. Cooper, J. Hails, K. Jones, F. Kwaku, L. Taylor, S. Hayman, S. Shaw, C. Kibbler, et al. Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study J. Antimicrob. Chemother., February 1, 2004; 53(2): 345 - 355. [Abstract] [Full Text] [PDF]

				D. Annane, P. Aegerter, M. C. Jars-Guincestre, and B. Guidet Current Epidemiology of Septic Shock: The CUB-Rea Network Am. J. Respir. Crit. Care Med., July 15, 2003; 168(2): 165 - 172. [Abstract] [Full Text] [PDF]

				C. Alberti, C. Brun-Buisson, S. V. Goodman, D. Guidici, J. Granton, R. Moreno, M. Smithies, O. Thomas, A. Artigas, and J. R. Le Gall Influence of Systemic Inflammatory Response Syndrome and Sepsis on Outcome of Critically Ill Infected Patients Am. J. Respir. Crit. Care Med., July 1, 2003; 168(1): 77 - 84. [Abstract] [Full Text] [PDF]

				P. Eggimann, S. Harbarth, B. Ricou, S. Hugonnet, K. Ferriere, P. Suter, and D. Pittet Acute Respiratory Distress Syndrome after Bacteremic Sepsis Does Not Increase Mortality Am. J. Respir. Crit. Care Med., May 1, 2003; 167(9): 1210 - 1214. [Abstract] [Full Text] [PDF]

				S. Harbarth, K. Ferriere, S. Hugonnet, B. Ricou, P. Suter, and D. Pittet Epidemiology and Prognostic Determinants of Bloodstream Infections in Surgical Intensive Care Arch Surg, December 1, 2002; 137(12): 1353 - 1359. [Abstract] [Full Text] [PDF]

				S. Shafazand and A. B. Weinacker Blood Cultures in the Critical Care Unit: Improving Utilization and Yield Chest, November 1, 2002; 122(5): 1727 - 1736. [Abstract] [Full Text] [PDF]

				W. A. Krueger, F.-P. Lenhart, G. Neeser, G. Ruckdeschel, H. Schreckhase, H.-J. Eissner, H. Forst, J. Eckart, K. Peter, and K. E. Unertl Influence of Combined Intravenous and Topical Antibiotic Prophylaxis on the Incidence of Infections, Organ Dysfunctions, and Mortality in Critically Ill Surgical Patients: A Prospective, Stratified, Randomized, Double-Blind, Placebo-controlled Clinical Trial Am. J. Respir. Crit. Care Med., October 15, 2002; 166(8): 1029 - 1037. [Abstract] [Full Text] [PDF]

				B. RENAUD and C. BRUN-BUISSON Outcomes of Primary and Catheter-related Bacteremia . A Cohort and Case-Control Study in Critically Ill Patients Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1584 - 1590. [Abstract] [Full Text] [PDF]

				T. G. Liou, F. R. Adler, S. C. FitzSimmons, B. C. Cahill, J. R. Hibbs, and B. C. Marshall Predictive 5-Year Survivorship Model of Cystic Fibrosis Am. J. Epidemiol., February 15, 2001; 153(4): 345 - 352. [Abstract] [Full Text] [PDF]

				D. PITTET, S. HARBARTH, P. M. SUTER, K. REINHART, A. LEIGHTON, C. BARKER, F. MACDONALD, E. ABRAHAM, and the Ro 45-2081 Study Group Impact of Immunomodulating Therapy on Morbidity in Patients with Severe Sepsis Am. J. Respir. Crit. Care Med., September 1, 1999; 160(3): 852 - 857. [Abstract] [Full Text]

				A. P. Wheeler and G. R. Bernard Treating Patients with Severe Sepsis N. Engl. J. Med., January 21, 1999; 340(3): 207 - 214. [Full Text] [PDF]

				S. Harbarth, O. Rutschmann, P. Sudre, and D. Pittet Impact of Methicillin Resistance on the Outcome of Patients With Bacteremia Caused by Staphylococcus aureus Arch Intern Med, January 26, 1998; 158(2): 182 - 189. [Abstract] [Full Text] [PDF]

				M. H. KOLLEF, J. VLASNIK, L. SHARPLESS, C. PASQUE, D. MURPHY, and V. FRASER Scheduled Change of Antibiotic Classes . A Strategy to Decrease the Incidence of Ventilator-associated Pneumonia Am. J. Respir. Crit. Care Med., October 1, 1997; 156(4): 1040 - 1048. [Abstract] [Full Text] [PDF]

				K. E. Sands, D. W. Bates, P. N. Lanken, P. S. Graman, P. L. Hibberd, K. L. Kahn, J. Parsonnet, R. Panzer, E. J. Orav, D. R. Snydman, et al. Epidemiology of Sepsis Syndrome in 8 Academic Medical Centers JAMA, July 16, 1997; 278(3): 234 - 240. [Abstract] [PDF]